SEC 13F Intelligence

Cheyne Capital Management (UK) LLP / VKTX

Cheyne Capital Management (UK) LLP’s Viking Therapeutics Inc Position

Does Cheyne Capital Management (UK) LLP own Viking Therapeutics Inc (VKTX)? Not currently — the last reported position was 64.8K shares worth $608,678 in Q4 2022; the fund’s latest 13F (Q4 2023) no longer reports it.

Position Value
$608,678
Q4 2022
Shares
64.8K
% of Portfolio
+1.06%
Quarters Held
1
position exited

Position History VKTX

Reported value by quarter
Q4 ’22: $608,678Q4 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202264.8K$608,678+1.06%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cheyne Capital Management (UK) LLP’s full portfolio or all institutional holders of VKTX.